Evidence map›Paper›PMID 36314822›Full record

ArticleJournal of virology2022

pUL36 Deubiquitinase Activity Augments Both the Initiation and the Progression of Lytic Herpes Simplex Virus Infection in IFN-Primed Cells.

Jonas Mohnke, Irmgard Stark, Mara Fischer, Patrick M Fischer, Andreas Schlosser, Arnhild Grothey, Peter O'Hare, Beate Sodeik, Florian Erhard, Lars Dölken and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jonas Mohnke *Institut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Irmgard Stark *Institut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Mara FischerInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Patrick M FischerInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Andreas SchlosserRudolf-Virchow-Zentrum - Center for Integrative and Translational Bioimaging, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Arnhild GrotheyInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Peter O'HareDepartment of Virology, Imperial College London, Norfolk Place, London, United Kingdom.ORCID 0000-0003-4508-5602
Beate SodeikInstitut für Virologie, Medizinische Hochschule Hannover, Hannover, Germany.
Florian ErhardInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Lars DölkenInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
Thomas HennigInstitut für Virologie und Immunbiologie, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID 0000-0002-7788-1681
University of Würzburg · DEImperial College London · GBMedizinische Hochschule Hannover · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

The evolutionarily conserved, structural HSV-1 tegument protein pUL36 is essential for both virus entry and assembly. While its N-terminal deubiquitinase (DUB) activity is dispensable for infection in cell culture, it is required for efficient virus spread

Indexed as

Deubiquitinating EnzymesHerpes SimplexHerpesvirus 1, HumanViral ProteinsHumansInterferonsVirus ReplicationDeubiquitinating EnzymesInterferonsUL36 protein, Human herpesvirus 1Viral ProteinsDUBherpes simplex virus 1HSV-1innate immunityinterferoninterferon antagonismubiquitinUL36USP

Identifiers

PMID36314822
PMCPMC9683058
OpenAlexW4307776004

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.